Retraction

Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer

Citations (13)

13
Total Citations
2
Post-Retraction
(15.4%)
11
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
0 After 2+ years
200 Days since retraction (latest)
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
Fumiaki Takatsu, Ken Suzawa, Shuta Tomida et al. (19 authors)
Journal of Molecular Medicine
Published: Oct 2023
17 citations
200 days after retraction
The role of integrin family in bone metabolism and tumor bone metastasis
Liwei Mao, Lian Wang, Jiake Xu et al. (4 authors)
Cell Death Discovery Open Access
Published: Apr 2023
39 citations
14 days after retraction
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou et al. (6 authors)
Frontiers in Pharmacology Open Access
Published: Mar 2023
20 citations
3 days before retraction
In vitro model of predicting metastatic ability using tumor derived extracellular vesicles; beyond seed soil hypothesis
Kinjal Bhadresha, Vinal Upadhyay, Jpan Brahmbhatt et al. (6 authors)
Scientific Reports Open Access
Published: Nov 2022
5 citations
123 days before retraction
Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression
Katarzyna Ratajczak‐Wielgomas, Alicja Kmiecik, Piotr Dzięgiel
International Journal of Molecular Sciences Open Access
Published: Jan 2022
20 citations
429 days before retraction
Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases
Chuanyu Sun, Yuanyuan Mi, Shengyang Ge et al. (10 authors)
Frontiers in Oncology Open Access
Published: Jan 2022
5 citations
440 days before retraction
Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors?
Wei Zhang, Fahong Wu, Jia Wang et al. (6 authors)
Neoplasma Open Access
Published: Jan 2022
1 citation
450 days before retraction
Diagnostic value of periostin in lung cancer‐related malignant pleural effusion
Jinjin Zhang, Tongtong Zha, Na Zhang et al. (4 authors)
Journal of Clinical Laboratory Analysis Open Access
Published: Dec 2021
4 citations
455 days before retraction
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
Emmanuel Massy, J-C. Rousseau, M Gueye et al. (18 authors)
Journal of bone oncology Open Access
Published: Jun 2021
10 citations
660 days before retraction
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni et al. (8 authors)
BMC Cancer Open Access
Published: Jan 2021
24 citations
802 days before retraction
Research status and the prospect of POSTN in various tumors
Yue Yu, Changming Tan, Yuanyuan Jia
Neoplasma Open Access
Published: Jan 2021
11 citations
815 days before retraction
Prognostic significance of periostin in colorectal cancer
Xingming Deng, Sheng Ao, Jianing Hou et al. (6 authors)
Chinese Journal of Cancer Research Open Access
Published: Jan 2019
17 citations
1546 days before retraction
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
Laura González‐González, Javier Alonso
Frontiers in Oncology Open Access
Published: Jun 2018
257 citations
1749 days before retraction
Quick Stats
Total Citations: 13
Years Since Retraction: 2.7 years
Open Access: Yes
Last Checked: Jul 24, 2025